Lang Matthew
SEC CIK 1712069 · EDGAR
Most active insiders at GPCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Berrios John Joseph | Chief Commercial Off | — | — |
| 2 | Coll Crespo Blas | Chief MEDICAL Off | — | — |
| 3 | Ma Yingli | CTO | — | — |
| 4 | Lin Xichen | CSO | — | — |
| 5 | Yoon Jun | CFO | — | — |
| 6 | Hall Ashley | Chief Development Off | — | — |
| 7 | Lang Matthew | COO, GC | — | — |
| 8 | Stevens Raymond C | CEO, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-23 16:21 | 2026-04-15 | GPCR | Structure Therapeutics Inc. | Lang Matthew | COO, GC | A - Grant | $0.00 | +184.6K | 184.6K | New | $0 |
| D | 2025-02-26 | 2025-02-10 | LYEL | Lyell Immunopharma, Inc. | Lang Matthew | Chief Business Off | A - Grant | $0.00 | +112.5K | 162.5K | +225% | $0 |
| D | 2024-02-13 | 2024-02-09 | LYEL | Lyell Immunopharma, Inc. | Lang Matthew | Chief Business Off | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations